Silver Oak Advisory Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Silver Oak Advisory Group's BIO Position: Q3 2026 in Review
Silver Oak Advisory Group held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 682 shares worth $258K. The position accounts for 0.1% of the portfolio, ranked #68.
Silver Oak Advisory Group first reported a position in BIO in Q1 2023 and has held it in 13 quarters since. The position peaked at $429K in Q1 2023. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Silver Oak Advisory Group held 682 shares of Bio-Rad Laboratories Class A worth $258K as of Q3 2026.
- Silver Oak Advisory Group left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up 0.1% of Silver Oak Advisory Group's portfolio in Q3 2026, its #68 holding.
- Silver Oak Advisory Group first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 13 quarters since.
- Silver Oak Advisory Group's Bio-Rad Laboratories Class A position peaked at $429K in Q1 2023.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Silver Oak Advisory Group's 13F filing for Q3 2026, filed 6 Nov 2026.